Literature DB >> 4835697

Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver.

S C Li, C C Wan, M Y Mazzotta, Y T Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4835697     DOI： 10.1016/s0008-6215(00)80383-3

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN： 0008-6215            Impact factor:   2.104


× No keyword cloud information.
  10 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Evidence for two cDNA clones encoding human GM2-activator protein.

Authors:  S Nagarajan; H C Chen; S C Li; Y T Li; J M Lockyer
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

3.  Saposin A: second cerebrosidase activator protein.

Authors:  S Morimoto; B M Martin; Y Yamamoto; K A Kretz; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.

Authors:  S Morimoto; Y Yamamoto; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon.

Authors:  T Tamaru; S Fujibayashi; W R Brown; D A Wenger
Journal:  Histochemistry       Date:  1986

6.  The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver.

Authors:  P S Cheetham; N E Dance
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

7.  Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.

Authors:  K Inui; D A Wenger
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

8.  Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.

Authors:  K A Kretz; G S Carson; S Morimoto; Y Kishimoto; A L Fluharty; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

10.  Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.

Authors:  P Hechtman; Z Kachra
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.